LL-37 · Research brief
LL-37 Research Journaling Template: What to Log
Short answer
An LL-37 research journaling template is a fixed set of fields your team completes every time a vial is received, stored, sampled, or depleted: entry date and initials, compound and catalog name, lot or batch number, the matching certificate of analysis (COA) reference, supplier and order number, receipt condition, storage location, solution preparation record, project identifier, observations, deviations, and disposal.…
LL-37 Research Journaling Template: What to Log
An LL-37 research journaling template is a fixed set of fields your team completes every time a vial is received, stored, sampled, or depleted: entry date and initials, compound and catalog name, lot or batch number, the matching certificate of analysis (COA) reference, supplier and order number, receipt condition, storage location, solution preparation record, project identifier, observations, deviations, and disposal. The point of the template is not tidier notes. It is the ability to trace any single observation back to a specific batch of material with published third-party analysis standing behind it. Build the structure once in whatever system you already use — spreadsheet, lab notebook, inventory platform — and make every field mandatory. Fields that can be skipped will be.
LL-37 is a research compound. Studies describe it as a host-defense peptide investigated in antimicrobial and immunomodulatory research contexts, and the literature is still developing. Nothing in this article is a protocol, a dosing reference, or guidance for use in humans or animals — all compounds discussed here are for laboratory research use only. What follows is documentation architecture for the business side: how a med spa owner, clinic operator, telehealth founder, or reseller who stocks research materials should structure records so that a question raised six months from now has an answer.
Why a fixed structure beats freeform notes
Freeform notes drift. Two people recording the same event will capture different details, and the one detail nobody wrote down is always the one that matters later. The realistic failure scenario for a business holding inventory is not a scientific dispute — it is a practical one. A batch behaves differently than the one before it. A downstream buyer asks which lot they received. An internal review asks where a particular vial went. Someone leaves the company and takes the institutional memory with them.
A template solves this by making records comparable and searchable. If every entry carries the same lot field in the same format, you can pull the full history of that lot in seconds rather than reconstructing it from invoices and recollection. For a business building a catalog, this is also the difference between a professional operation and an improvised one. Buyers, partners, and payment processors all read documentation quality as a proxy for how seriously you run the rest of the business.
The second reason is less obvious: a good template forces you to ask your supplier for the right information before you buy. Half the fields below cannot be filled in unless the supplier publishes the data. If you design the template first, gaps in a supplier's transparency show up as blank cells rather than as vague unease.
The core fields worth making mandatory
| Field | What goes in it | Why it matters |
|---|---|---|
| Entry date and initials | Date of the action, plus who performed it | Attribution is the backbone of any record |
| Compound and catalog name | The compound as listed by the supplier, plus stated mass per vial | Catalog naming varies between suppliers |
| Lot / batch number | Transcribed exactly as printed on the vial label | The single key that links material to testing |
| COA reference | File name, link, or archive ID of the certificate matching that lot | A COA for a different lot is not evidence |
| Supplier and order number | Vendor name and the order the vial arrived on | Lets you trace backward through purchasing |
| Receipt condition | Packaging intact, seals unbroken, cold-pack state on arrival | Documents condition before your custody begins |
| Storage location and conditions | Unit identifier and recorded temperature | Establishes where material has been held |
| Solution preparation record | Diluent used, volume, date prepared, prepared by | Records what was made, not how to make it |
| Project or protocol ID | The internal study or protocol the material supports | Connects material to purpose |
| Observations | What was measured, on what instrument, with the raw file name | Data without provenance is unusable |
| Deviations | Anything that departed from the written plan | Undocumented deviations are the most common gap |
| Disposal or depletion | Date, method, and who confirmed it | Closes the loop on every unit received |
Two notes on using this. First, keep the lot number and COA reference adjacent in your layout — visually pairing them makes a missing certificate obvious. Second, archive the COA file itself rather than a link to someone else's server. Links break. A dated PDF in your own storage survives a supplier redesigning their website.
Traceability starts on the purchase order
Every field above that depends on the supplier is a field you cannot audit yourself. This is where documentation projects quietly fail: the template is excellent, and the lot-to-COA column is empty because the vendor never published one.
So the first thing to evaluate is not the compound. It is whether the supplier's paperwork can populate your records. Ask for the analysis tied to your specific lot number, not a representative sample from an unspecified batch. Ask which laboratory performed it and what each panel actually covers — identity confirmation, purity determination, and contaminant screening are distinct questions, and a document that only reports one of them is not a full picture. Ask whether you can retrieve that document yourself, without emailing anyone.
The industry practices worth walking away from are consistent and easy to spot:
| What a supplier says | What you should be able to verify |
|---|---|
| "Pharmaceutical grade" | The phrase carries no defined meaning for research-use material — ask instead for measured purity on your lot |
| "Third-party tested" | The name of the lab and the actual report for your batch number |
| "High purity" | A dated certificate showing the HPLC result, not a marketing figure |
| "COA available on request" | A certificate you can pull yourself, unprompted, before ordering |
| "Contact us for pricing" | Terms and tier structure disclosed during a real application process |
| "Testing available for a fee" | Analysis included as standard, not sold back to you as an upgrade |
None of this requires accusing anyone of anything. It simply means your template's supplier-dependent fields should be filled before money moves, not after.
Storage, custody, and the entries people forget
The entries most often missing from an otherwise solid log are the boring ones. Record transfers between storage units, not just the original placement. Record temperature excursions — a freezer door left ajar over a weekend is exactly the kind of event that explains an anomaly later, and exactly the kind nobody writes down. Record who has physical access to storage, and log it again when that list changes.
If material moves between sites, treat each hand-off as its own entry with both parties identified. If a vial is set aside for any reason, log the reason rather than quietly shelving it. And close every record: each unit received should eventually have a depletion or disposal entry, so that your inventory count and your logbook agree. A log that only records arrivals will slowly diverge from reality until it is worthless.
For businesses stocking multiple compounds, add one more column — a category tag. Grouping entries by research area makes it far easier to review documentation across a whole catalog rather than one compound at a time, and it maps neatly onto how most suppliers organize their listings.
Compliance questions that belong with counsel, not a template
A journaling template is a business record, not a legal shield, and it cannot answer regulatory questions for you. Documentation and permission are separate issues.
The questions worth raising with a qualified attorney and, where relevant, your state licensing board include: how research-use-only material must be labeled if you resell or re-label it; what your obligations are as a distributor rather than an end user; whether your business structure and licensing posture permit the activity you are planning at all; what records you would need to produce if asked; and how any of this interacts with your professional license, if you hold one. Frameworks differ by jurisdiction and change over time, so these are questions to resolve with counsel who knows your situation — not points to settle from a blog post. Nothing here is legal advice.
Similarly, keep the scope of your records honest. Research documentation describes material, handling, and measurements. It does not describe use in people. If a question concerns animal health, that question belongs with a licensed veterinarian; if it concerns human health, it belongs with a licensed clinician. Your compliance obligations are yours and your counsel's domain, and no supplier — including Real Peptides — can assume them for you.
What Real Peptides does differently
Real Peptides is built around the fields your template cannot fill on its own. Compounds are supplied at 99%+ HPLC purity, and every batch goes through seven-panel testing. The resulting COAs are publicly verifiable — a prospective wholesale partner can look up lab results directly rather than requesting a document and waiting to see what arrives, and nothing is sold back as a paid add-on. That means the lot number, the COA reference, and the analysis behind them can all be captured in your records before an order is placed.
Fulfillment runs from within the United States, with orders shipping in five to seven days, which makes receipt dates predictable enough to plan inventory cycles around. Onboarding is a three-step wholesale application: apply, get reviewed for fit, and receive partner terms. Pricing and tier structure are handled inside that process rather than hidden behind an indefinite "contact us" loop.
Whether any specific compound — including LL-37 — is currently stocked is worth confirming against the live catalog before you build a plan around it, since availability changes. All material is supplied for laboratory research use only and is not an FDA-approved drug.
Where qualified buyers go next
If you are already running research documentation and the recurring problem is supplier paperwork rather than your own discipline, the fix is upstream. Build the template from the field list above, then apply to the Real Peptides Wholesale Partner Program and evaluate whether the published COAs, purity data, and batch testing actually populate the columns you need. If they do, you have a supplier your records can stand on.
For context on the breadth available to wholesale partners, Real Peptides organizes its catalog by research area — including gastrointestinal and epithelial research, where documentation-heavy compounds such as KPV Peptide 10mg sit alongside widely referenced options like BPC-157 10mg — and the same testing and COA standards apply across the popular peptides collection.
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA